Back
Contineum Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CTNM
Contineum Therapeutics, Inc.
Last Price:
$12.34
Seasonality Move:
-24.83%
7 Day Trial
ALL ACCESS PASS
$
7
Contineum Therapeutics, Inc. Stock Forecast
-
Is Contineum Therapeutics, Inc. Stock Undervalued?The current Contineum Therapeutics, Inc. [CTNM] share price is $12.26. The Score for CTNM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CTNM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Contineum Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Contineum Therapeutics, Inc. Stock Rating
Data Unavailable
Contineum Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contineum-tx.com
52-Week Data
52-Week High:
15.25
52-Week Low:
3.35
Prediction Charts
Market Cap:
317.2M
Price in USD:
12.26
Volume:
139.5K
Beta:
1.10
Technical Analysis
SMA50:
11.32
SMA100:
10.73
SMA200:
7.80
52-Wk Change:
-9.19%
Stock Predictions
-
Is Contineum Therapeutics, Inc. stock public?Yes, Contineum Therapeutics, Inc. is a publicly traded company.
-
What is the Contineum Therapeutics, Inc. stock quote today?The Contineum Therapeutics, Inc. stock price is 12.26 USD today.
-
How to buy Contineum Therapeutics, Inc. stock online?You can buy Contineum Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 10.53 | 11.12 | 11.15 | 10.46 |
| Dec-4 | 11.08 | 10.98 | 11.43 | 10.86 |
| Dec-5 | 11.02 | 11.04 | 11.05 | 10.89 |
| Dec-8 | 11.04 | 12.25 | 12.34 | 11.04 |
| Dec-9 | 12.26 | 12.50 | 13.00 | 12.05 |
| Dec-10 | 12.50 | 12.52 | 12.80 | 12.11 |
| Dec-11 | 12.60 | 13.07 | 13.48 | 12.41 |
| Dec-12 | 12.33 | 11.63 | 12.65 | 11.50 |
| Dec-15 | 11.61 | 11.58 | 11.85 | 11.58 |
| Dec-16 | 11.52 | 11.55 | 11.77 | 11.50 |
| Dec-17 | 11.62 | 11.48 | 12.00 | 11.48 |
| Dec-18 | 11.49 | 11.39 | 11.75 | 11.38 |
| Dec-19 | 11.32 | 11.74 | 11.88 | 11.27 |
| Dec-22 | 11.74 | 12.26 | 12.41 | 11.74 |
Contineum Therapeutics, Inc. Earnings
Data Unavailable
Contineum Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.19 per share.
* Contineum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.